Form D · Other Technology

ORBIS BIOSCIENCES, INC

Lenexa, KS · CIK 0001449477

Offering snapshot reported Apr 28, 2017 · SEC filing

Reported sold
$985K
Offering amount: $1.1M
Investors reported
11
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 17, 2016
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$493K$985KOct 31, 2016: $355,000.00Oct 31, 2016Apr 28, 2017: $985,000.00Apr 28, 2017

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$355,000 → $985,000
  • Reported investors8 → 11

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 28, 2017Amendment$985,000$630,000vs Oct 31, 201611SEC filing
Oct 31, 2016Initial$355,000No comparison8SEC filing
May 19, 2009Initial$250,000No comparisonNot reportedSEC filing
Nov 3, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-273532

Source: Form D, filed Apr 28, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Cory Berkland Director, Executive
James Clarke Director
Bowman Fishback Director
Maria Flynn Director, Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
8006 Reeder Street
Lenexa, KS, 66214